12
NEWS
Hello Miboko
A wearable sensor measures what's actually going
on inside your body, specifically, tracking your
metabolism and showing you how your body is
responding to sugar. We are very
excited, both with
the response that
we have had from
participants and
also the weight
loss results
that are being
reported ~ Dr Faz
Chowdhury
Nemaura Medical Inc is
a medical technology
company focused
on developing and
commercializing non-invasive
wearable diagnostic devices and
supporting personalized lifestyle
and weight reduction programs,
announces that it has commenced
patient studies of its proprietary
metabolic health programme,
Miboko, with the National
Health Service.
Miboko, is the first metabolic
tracking programme to integrate a
non-invasive glucose sensor with a
lifestyle app that includes recording
of food and drink, educational
content, and an analytics platform.
It gives the user a metabolic score
based on diet, exercise, and the
user's individual glucose response
to their food intake. Users are given
personalized recommendations
to help them reduce weight, avoid
serious health issues, such as heart
disease and diabetes, and enjoy a
better quality of life.
The partnership with the
UK's NHS is through medical
centres that partner with the NHS
National Institute for Health and
Care Research (NIHR) to gather
information that helps change and
save lives.
Mind/body/connect
Miboko is expected to be available
without prescription and is
recommended for use by those
wishing to lose weight. The program
will be offered to employers
and insurers, as well as direct to
consumers. In the US alone, the
programme will be relevant to over
80m people with pre-diabetes
as well as to people with obesity.
Significantly, Miboko will also be
used by people who wish to embark
on a diet programme, of which a
significant number will have tried
alternative diet plans. Miboko
complements the BEATdiabetes
programme that is being
commercialized for people with
Type 2 diabetes in the US through
strategic alliances.
Dr. Faz Chowdhury, Nemaura
Medical's Chief Executive Officer,
stated, "Use of glucose monitoring is
becoming more widespread, not just
in people with diabetes, but also with
those who wish to use personalized
data to aid in weight loss. Studies
have shown that glucose response
to diet and lifestyle habits can have
a profound behavioural impact in
helping people to modify their diet
and exercise regimes. We are very
excited, both with the response that
we have had from participants and
also the weight loss results that are
being reported."
www.NemauraMedical.com
www.miboko.com